Abbott Laboratories's market cap is currently $236.77B. The company's EPS TTM is $1.26; its P/E ratio is 16.83; and it has a dividend yield of 1.71%. Abbott Laboratories is scheduled to report earnings on July 17, 2025, and the estimated EPS forecast is $1.30. See an overview of income statement, balance sheet, and cash flow financials.
